REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 8 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,670 | +67.0% | 1,670 | -75.8% | 0.00% | – |
Q3 2022 | $1,000 | – | 6,901 | +1501.2% | 0.00% | – |
Q2 2022 | $0 | – | 431 | +84.2% | 0.00% | – |
Q3 2021 | $0 | – | 234 | +37.6% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 170 | -98.6% | 0.00% | – |
Q1 2021 | $6,000 | +500.0% | 12,457 | +1070.8% | 0.00% | – |
Q4 2020 | $1,000 | – | 1,064 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BlueCrest Capital Management Ltd | 1,235,000 | $222,000 | 0.01% |
Arena Investors LP | 85,000 | $15,000 | 0.01% |
UBS Group AG | 431 | $0 | 0.00% |
AQR Arbitrage LLC | 55,839 | $10,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Walleye Trading LLC | 65,752 | $12,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 57,064 | $10,000 | 0.00% |
Walleye Capital LLC | 89,623 | $16,000 | 0.00% |